Manifestaciones cardiovasculares en pacientes con lupus eritematoso sistémico en una institución de referencia en Cundinamarca, Colombia, durante un periodo de un año

Mason, 2005, The pathogenesis of systemic lupus erythematosus, 809 Villa-Forte, 2011, Cardiovascular disorders and rheumatic disease, Rev Esp Cardiol., 64, 809, 10.1016/j.recesp.2011.05.009 Urowitz, 2000, Accelerated atheroma in lupus-background, Lupus., 9, 161, 10.1191/096120300678828271 Molina, 1996, Systemic lupus erythematosus in males. A study of 107 Latin American patients, Medicine (Baltimore)., 75, 124, 10.1097/00005792-199605000-00002 Peña, 1997, Manifestaciones cardiacas del lupus eritematoso sistémico, Rev Colomb Reumatol., 4, 12 Crozier, 1990, Cardiac involvement in systemic lupus erythematosus detected by echocardiography, Am J Cardiol., 65, 1145, 10.1016/0002-9149(90)90329-Y Doria, 2005, Cardiac involvement in systemic lupus erythematosus, Lupus., 14, 683, 10.1191/0961203305lu2200oa Libman, 1924, A hitherto undescribed form of valvular and mural endocarditis, Archives of Internal Medicine., 33, 701, 10.1001/archinte.1924.00110300044002 Cervera, 1992, Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients, Ann Rheum Dis., 51, 156, 10.1136/ard.51.2.156 Moder, 1999, Cardiac involvement in systemic lupus erythematosus, Mayo Clin Proc., 74, 275, 10.4065/74.3.275 Khamashta, 1990, Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus, Lancet., 335, 1541, 10.1016/0140-6736(90)91373-I Sturfelt, 1992, Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population, Medicine (Baltimore)., 71, 216, 10.1097/00005792-199207000-00004 Finkelstein, 1997, Anti-Ro 1 (SSA) and anti-La (SSB) antibodies and complete congenital heart block, Ann Med Interne (Paris)., 148, 205 James, 1965, Pathology of the cardiac conduction system in systemic lupus erythematosus, Ann Intern Med., 63, 402, 10.7326/0003-4819-63-3-402 Petri, 1992, Risk factors for coronary artery disease in patients with systemic lupus erythematosus, Am J Med., 93, 513, 10.1016/0002-9343(92)90578-Y Borba, 1997, Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies, Lupus., 6, 533, 10.1177/096120339700600610 D’Cruz, 2002, Cardiovascular manifestations of systemic lupus erythematosus, 645 Gustafsson, 2009, Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study, Arthritis Res Ther., 11, R186, 10.1186/ar2878 Magder, 2012, Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus, Am J Epidemiol., 176, 708, 10.1093/aje/kws130 Roman, 2003, Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus, N Engl J Med., 349, 2399, 10.1056/NEJMoa035471 Asanuma, 2003, Premature coronary-artery atherosclerosis in systemic lupus erythematosus, N Engl J Med., 349, 2407, 10.1056/NEJMoa035611